Journal of Diabetes Research / 2019 / Article / Fig 1

Research Article

A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA’s Ability to Inhibit Inflammatory T Cells

Figure 1

Alprazolam reduces islet cell apoptosis in human islet xenografts. Mice receiving human islet grafts were treated IP with vehicle or alprazolam (0.25 or 0.75 mg/kg/day IP) and/or GABA through their drinking water (6 mg/ml) or water alone. The frequency of apoptotic cells in the different groups of recipients was determined by TUNEL and anti-insulin staining assays. All control and experimental groups were tested side by side. Data are a representative image (magnification ×400) or expressed as the mean % of apoptotic islet of each group (-6 mice) from four islet donors in four separate experiments (with one islet donor for each experiment). (a) A representative image of apoptotic islet cells (red) and insulin+β-cells (green) in human islet grafts. Scale bar = 25 μm. (b) Frequency of apoptotic cells. (c) Frequency of insulin+β-cells. White arrows indicate apoptotic cells. , , and vs. the control with vehicle injection and plain water. vs. GABA treated. vs. the alprazolam (0.25 mg/kg/day) and vs. the alprazolam (0.75 mg/kg/day).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.